Enterprise Program

SleepMed is your partner in population health management for untreated Sleep Apnea and related conditions.  In 2016 Frost & Sullivan estimated that OSA afflicts 29.4 million American men and women, which represents 12 percent of the U.S. adult population. They also calculated that diagnosing and treating every patient in the U.S. who has sleep apnea would produce an annual economic savings of $100.1 billion

Costs of Undiagnosed OSA vs Diagnosed (Frost & Sullivan 2016)

Total Costs (Undiagnosed)
Cost per Person (Undiagnosed)
Collisions per year
Total cost (Diagnosed, 90% less)
Cost per Person (Diagnosed, 60% less)
Collisions per year (30% less)

Partner with us

call us 1-800-SLEEPMED

OSA negatively affects Medical Costs, Productivity and Safety

Medical Expenses

Sleep disorders contribute to and worsen heart disease, diabetes and obesity.


People with untreated sleep disorders are 3x more likely to miss work, and 1.5x more likely to be hospitalized.

Workplace Safety

Untreated sleep disorders result in 3x workplace accidents

The benefits of a Sleep Care Program


PMPM savings for those on PAP therapy versus those non-compliant


better patient compliance than competing programs


reduction in preventable accidents

  1. General
  2. Population Health
  3. Wellness
  4. Enteprise Spend
  5. Active Management
  6. Therapy
  • Leading integrated sleep service provider

    Leading integrated sleep service provider

  • Data Driven

    Data Driven

  • Streamline


  • Access to care

    Access to care

  • Compliance


  • Services



Sleep Apnea has been documented as a major health hazard for employees in the transportation industry. From pilots to train drivers, testing for OSA is either obligatory or advisable to help avoid accidents at work. SleepMed has developed a unique chain of custody receiver for ARES™ that documents continuous wear until removed by the clinician, thus ensuring compliance with OSA testing.